Koh KK, et al. Circulation. 2004

More documents

Recommendations

Info

Combined therapy or fenofibrate <strong>al</strong>one significantly increases Adiponectin levels in patients with combined hyperlipidemia 30 % Change in Adiponectin Levels (%) 20 10 P
Combined therapy or fenofibrate <strong>al</strong>one significantly increases Insulin sensitivity in patients with combined hyperlipidemia 15 % Change in QUICKI (%) 10 5 P
Page 2 and 3: 혈관연구회 창립 심포지움
Page 4 and 5: Nitric Oxide • Regulates vasomoto
Page 7: Reactive Hyperemia
Page 10 and 11: 40 Subjects with a Parental History
Page 12 and 13: Kaplan-Meier Analysis of Patients w
Page 14 and 15: Cytokines LDL ox Ang II LPS CMV NAD
Page 16 and 17: Association Between MCP-1 Levels an
Page 18 and 19: Top, Rapid angiographic stenosis pr
Page 20 and 21: Therapeutic Intervention Cytokines
Page 22 and 23: Effects of Fenofibrate on Inflammat
Page 26 and 27: Ramipril Combined with Simvastatin
Page 28 and 29: Additive Beneficial Effects of Rami
Page 30 and 31: Effects of Simvastatin, Combined Th
Page 32 and 33: ThankQ!
Page 34 and 35: Fenofibrate • Peroxisome Prolifer
Page 36 and 37: Fenofibrate suppresses inflammatory
Page 38 and 39: 10 Effects of Fenofibrate on Vasomo
Page 40 and 41: % Change in MDA Levels (%) Effects
Page 42: Combined Therapy Significantly Redu

Koh KK, et al. Circulation. 2004

Create successful ePaper yourself

Delete template?

Save as template?